Differential cholinoceptor subtype-dependent activation of signal transduction pathways in neonatal versus adult rat atria

Biochemical Pharmacology

Volumn 53, Issue 7, 1997, Pages 959-967

  Borda, Enri S ^a   Perez Leiros, Claudia ^a   Camusso, Juan Jose ^a   Bacman, Sandra ^a   Sterin Borda, Leonor ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

cAMP; cGMP; heart contractility; M1 and M2 subtypes; mAChR; neonatal and adult atria; NOS activity; PI hydrolysis

Indexed keywords

CARBACHOL; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG RECEPTOR BINDING; HEART ATRIUM; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CARBACHOL; HEART; HEART ATRIA; INOSITOL PHOSPHATES; MUSCARINIC AGONISTS; MYOCARDIAL CONTRACTION; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION;

EID: 0343416795     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00866-0     Document Type: Article

References (37)

1. Eglen RM and Whiting RL, Muscarinic receptor subtypes: A critique of the current classification and a proposal of a working nomenclature. J Auton Pharmacol 5: 323-346, 1986.
2. Hammer R, Berrie CP, Birdsall NJ, Burgen AS and Hulme EC, Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283: 90-92, 1980.
3. Kubo T, Maeda A, Sugimoto K, Ichiyama A, Kangawa K, Matsuo H, Hirose T and Numa S, Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from cDNA sequence. FEBS Lett 209: 367-372, 1986.
4. 2 muscarinic receptor. Science 236: 600-605, 1987.
5. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J and Capon DJ, Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 6: 3923-3929, 1987.
6. Bonner TI, Young AC, Brann MR and Buckley NJ, Identification of a family of muscarinic receptor genes. Science 237: 527-532, 1987.
7. Lechleiter J, Hellmiss R, Duerson K, Ennulat D, David N, Clapham D and Peralta E, Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes. EMBO J 9: 4381-4390, 1990.
8. Hosey MM, Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors. FASEB J 6: 845-852, 1992.
9. Ashkenazi A, Winslow JW, Peralta EG, Peterson GL, Schimerlik MI, Capon DJ and Ramachandran J, An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 238: 672-675, 1987.
10. Peralta EG, Ashkenazi A, Winslow JW, Ramachandran J and Capon DJ, Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature 334: 434-437, 1988.
11. Evans T, Smith MM, Tanner LI and Harden TK, Muscarinic cholinergic receptors of two cell lines that regulated cyclic AMP metabolism by different molecular mechanisms. Mol Pharmacol 26: 395-404, 1984.
12. Sterin-Borda L, Vila Echagüe A, Perez Leiros C, Genaro A and Borda E, Endogenous nitric oxide signalling system and the cardiac muscarinic acetylcholine receptor-inotropic response. Br J Pharmacol 115: 1525-1531, 1995.
13. Shapiro RA, Scherer NM, Mabecker BA, Subers EM and Nathanson NM, Isolation, sequence, and functional expression of the mouse M1 muscarinic acetylcholine receptor gene. J Biol Chem 263: 18397-18403, 1988.
14. 2 muscarinic receptor binding sites in the murine cerebral cortex and heart. J Pharmacol Exp Ther 235: 612-618, 1985.
15. Camusso JJ, Sterin-Borda L, Rodriguez M, Bacman S and Borda ES, Pharmacological evidence for the existence of different subtypes of muscarinic acetylcholine receptors for phosphoinositide hydrolysis in neonatal versus adult rat atria. J Lipid Mediat Cell Signal 12: 1-10, 1995.
16. van Rossum JM, Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 143: 299-330, 1963.
17. Berridge MJ, Inositol triphosphate and diacylglycerol as second messengers. Biochem J 220: 345-360, 1984.
18. Cremaschi GA and Sterin-Borda L, Stimulation of phosphoinositide hydrolysis via class I antigen-specific recognition in murine cardiac tissue. FEBS Lett 249: 302-306, 1989.
19. Bredt DS and Snyder SH, Nitric oxide mediates glutamate-linked enhancement of cyclic GMP levels in the cerebellum. Proc Natl Acad Sd USA 86: 9030-9033, 1989.
20. Brown JH and Brown SL, Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation. J Biol Chem 259: 3777-3781, 1984.
21. Brown BL, Albano JD, Ekins RP and Sgherzi AM, Simple and selective saturation assay method for the measurement of adenosine 3′,5′-cyclic monophosphate. Biochem J 121: 561-562, 1971.
22. Goin JC, Perez Leiros C, Borda ES and Sterin-Borda L, Human chagasic IgG and muscarinic cholinergic receptor interaction: Pharmacological and molecular evidence. Mol Neuropharmacol 3: 189-196, 1994.
23. Bacman S, Sterin-Borda L, Camusso JJ, Hubscher O, Arana R and Borda ES, Circulating antibodies against neurotransmitter receptor activities in children with congenital heart block and their mothers. FASEB J 8: 1170-1176, 1994.
24. Mundson PJ and Rodbard D, LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239, 1980.
25. Rosen MR, Steinberg SF and Danilo P Jr, Developmental changes in the muscarinic stimulation of canine Purkinje fibers. J Pharmacol Exp Ther 254: 356-361, 1990.
26. Sun LS, Vulliemoz Y, Huber F, Bilezikian JP and Robinson RB, An excitatory muscarinic response in neonatal rat ventricular myocytes and its modulation by sympathetic innervation. J Mol Cell Cardiol 26: 779-787, 1994.
27. McMahon KK, Developmental changes of G proteins-muscarinic cholinergic receptor interactions in rat heart. J Pharmacol Exp Ther 251: 372-377, 1989.
28. 2 muscarinic receptor subtypes. Life Sci 32: 3001-3011, 1983.
29. Yang CM, Chen FF, Sung TC, Hsu HF and Wu D, Pharmacological characterization of muscarinic receptors in neonatal rat cardiomyocytes. Am J Physiol 265: C666-C673, 1993.
30. Croury I, Duzic E and Lanier SM, Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. J Biol Chem 267: 9852-9857, 1992.
31. Fleming JW, Wisler PL and Watanabe AM, Signal transduction by G proteins in cardiac tissues. Circulation 85: 420-433, 1992.
32. Luetje CW, Gierschik P, Milligan G, Unson C, Spiegel A and Nathanson N, Tissue-specific regulation of GTP-binding protein and muscarinic acetylcholine receptor levels during cardiac development. Biochemistry 26: 4876-4884, 1987.
33. Steinberg SF, Drugge ED, Bilezikian JP and Robinson RB, Acquisition by innervated cardiac myocytes of a pertussis toxin-specific regulatory protein linked to the α-receptor. Science 30: 186-188, 1985.
34. Longabaugh JP, Vatner DE, Vatner SF and Homey CJ, Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure. J Clin Invest 81: 420-424, 1988.
35. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA and Van Dop C, Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 82: 189-197, 1988.
36. Morris SA, Tanowitz H, Factor SM, Bilezikian JP and Wittner M, Myocardial adenylate cyclase activity in acute murine Chagas' disease. Circ Res 62: 800-810, 1988.
37. Kessler PD, Cates AE, Van Dop C and Feldman AM, Altered G protein function in the cardiomyopathic Syrian hamster. Circulation 78: II-560, 1988.